Global Cord Blood (CO) Upgraded by TheStreet to B-

Share on StockTwits

Global Cord Blood (NYSE:CO) was upgraded by investment analysts at TheStreet from a “c+” rating to a “b-” rating in a report released on Wednesday.

Separately, ValuEngine lowered shares of Global Cord Blood from a “buy” rating to a “hold” rating in a report on Wednesday, January 2nd.

Global Cord Blood stock opened at $6.95 on Wednesday. The stock has a market cap of $836.27 million, a PE ratio of 24.57 and a beta of 0.42. Global Cord Blood has a 1-year low of $5.67 and a 1-year high of $11.95.

Several institutional investors have recently bought and sold shares of CO. BlackRock Inc. raised its stake in Global Cord Blood by 2,935.0% in the fourth quarter. BlackRock Inc. now owns 7,284 shares of the medical research company’s stock worth $47,000 after buying an additional 7,044 shares in the last quarter. Virtu Financial LLC bought a new position in Global Cord Blood in the fourth quarter worth about $87,000. GSA Capital Partners LLP raised its stake in Global Cord Blood by 14.6% in the fourth quarter. GSA Capital Partners LLP now owns 18,944 shares of the medical research company’s stock worth $122,000 after buying an additional 2,411 shares in the last quarter. PNC Financial Services Group Inc. raised its stake in Global Cord Blood by 43.6% in the third quarter. PNC Financial Services Group Inc. now owns 32,920 shares of the medical research company’s stock worth $230,000 after buying an additional 10,000 shares in the last quarter. Finally, Panagora Asset Management Inc. raised its stake in Global Cord Blood by 6,962.3% in the third quarter. Panagora Asset Management Inc. now owns 40,467 shares of the medical research company’s stock worth $283,000 after buying an additional 39,894 shares in the last quarter. Institutional investors own 17.07% of the company’s stock.

About Global Cord Blood

Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services.

Read More: Backdoor Roth IRA

Receive News & Ratings for Global Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Observer Price Tops $0.0018
Observer Price Tops $0.0018
$0.02 Earnings Per Share Expected for First Solar, Inc.  This Quarter
$0.02 Earnings Per Share Expected for First Solar, Inc. This Quarter
Kenadyr Mining  Reaches New 1-Year Low at $0.06
Kenadyr Mining Reaches New 1-Year Low at $0.06
PlayCoin [ERC20]   Trading 30.1% Lower  Over Last 7 Days
PlayCoin [ERC20] Trading 30.1% Lower Over Last 7 Days
$5.30 Billion in Sales Expected for Mcdonald’s Corp  This Quarter
$5.30 Billion in Sales Expected for Mcdonald’s Corp This Quarter
Rizal Resources  Sets New 1-Year Low at $0.01
Rizal Resources Sets New 1-Year Low at $0.01


© 2006-2019 Ticker Report